Trial Profile
Imaging Biomarkers of Pulmonary Inflammation.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Aug 2015
Price :
$35
*
At a glance
- Drugs Drotrecogin alfa (Primary) ; Lovastatin (Primary)
- Indications Hyperlipidaemia; Thrombosis
- Focus Biomarker; Pharmacodynamics
- 16 Sep 2008 New trial record.